Press Release – Page 32 – Newswire Pakistan

November 21, 2023

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of NuScale Power Corporation (NYSE: SMR) between March 15, 2023 and November 8, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2024.

SO WHAT: If you purchased NuScale securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the NuScale class action, go to https://rosenlegal.com/submit-form/?case_id=19967 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) because of the effect of inflationary pressures on the cost of construction and power, the Company and Utah Associated Municipal Power Systems (“UAMPS”) would be unable to sign up enough subscribers to fulfill the Carbon Free Power Project (the “CFPP”); (2) Standard Power did not have the financial ability to support its agreement with NuScale; and (3) as a result, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the NuScale class action, go to https://rosenlegal.com/submit-form/?case_id=19967 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8982547

November 21, 2023

Growth of Boyden Turkiye Drives Expansion into Azerbaijan

Boyden enhances cross-border capabilities to Turkish and Azeri companies seeking world class leadership talent

Growth for Boyden Turkiye

Boyden Turkiye adds new partner and principals.

ISTANBUL, Nov. 20, 2023 (GLOBE NEWSWIRE) — Boyden, a premier global leadership and talent advisory firm, announces the expansion of its business in Turkiye with new offices in Azerbaijan. The extended team will enhance the close business relationship between the two nations through a seamless, cross-border approach to executive search and leadership consulting.

Turkish companies in Azerbaijan and Azeri companies in Turkiye will benefit from one local contact for both markets, through Murat Ergene and Ibrahim Paksoy, Managing Partners in Turkiye, and Allahverdi Baghirov, Principal in Azerbaijan. Collaboration is further strengthened by two new Principals who join the team in Turkiye, Hande Dönmez Osma and Melis Ertürk Keskin.

“We understand the complex challenges facing our clients and have robust resources to meet their needs, comments Murat Ergene, Managing Partner, Boyden Turkiye. “Through our global partnership we draw upon our collective insight into the evolution of different industries, the global talent pool and the leadership needs of organisations worldwide”.

“Boyden has served clients in Turkiye for twenty-five years, and is distinctive in providing locally-rooted, cross-border capabilities,” adds Ibrahim Paksoy, Managing Partner, Boyden Turkiye. “Clients value our client-centric approach and previous multinational experience in senior-level roles. We are delighted to welcome Allahverdi in Baku, and look forward to delivering exceptional outcomes through synergies in the region and with our global colleagues”.

Based in Azerbaijan, Allahverdi Baghirov brings to Boyden over 15 years’ experience in HR leadership, consulting on human resource management, executive search, leadership development and assessment. Before joining Boyden, he was CHRO, Executive Board Member at Araz Supermarket MMC, Chief Administrative Officer at UBN Ltd, and Head of HR at Gilan Holding. His consulting capabilities have a strong academic base; he is also Adjunct Lecturer at Baku Higher Oil School in Baku, Azerbaijan.

About Boyden

Boyden is a premier leadership and talent advisory firm with more than 70 offices in over 45 countries. Our global reach enables us to serve client needs anywhere they conduct business. We connect great companies with great leaders through executive search, interim management and leadership consulting solutions. Boyden is ranked amongst the top companies on Forbes’ Americas Best Executive Recruiting Firms for 2023. For further information, visit www.boyden.com.

Contacts:

Chris Swee
Chief Marketing Officer, Boyden
T: +1 914 747 0172
E: cswee@boyden.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6aeb0fb9-c3a8-448d-9d3d-48208f73f13d

GlobeNewswire Distribution ID 8982414

November 21, 2023

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Adobe Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ADBE

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds behalf of purchasers of common stock of Adobe Inc. (NASDAQ: ADBE) between July 23, 2021 and September 15, 2022, both dates inclusive (the “Class Period”), of the important December 19, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Adobe common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Adobe class action, go to https://rosenlegal.com/submit-form/?case_id=20021 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 19, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, during the Class Period, Defendants falsely downplayed competition from Figma, which provides a simple web-based tool for designing user interfaces, and misleadingly suggested that Adobe’s existing offerings were adequate to counter any harms the Company may have otherwise faced due to Figma’s growing market position. As a result, certain statements were materially false and misleading because they failed to disclose that: (1) Figma was growing its market share and was becoming a leader in user experience design; (2) Figma was in direct competition with Adobe on user experience design; (3) Adobe’s product “Express” was not an effective counter to Figma’s growing market share in bringing new customers to Adobe’s paid offerings; (4) Adobe’s other offerings were not succeeding in competing with Figma on user experience design; and (5) Adobe was losing market share to Figma. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Adobe class action, go to https://rosenlegal.com/submit-form/?case_id=20021 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

GlobeNewswire Distribution ID 8982448

November 20, 2023

Axi launches Select Your Edge campaign with Manchester City stars

Broker enlists Man City stars to introduce their new capital allocation programme, Axi Select

SYDNEY, Australia, Nov. 20, 2023 (GLOBE NEWSWIRE) — Leading online FX and CFD broker Axi has launched their new campaign, Select Your Edge. Featuring stars of Manchester City FC, the campaign introduces Axi’s new capital allocation programme, Axi Select.

Since 2020, Axi, the Official Online Trading Partner of Manchester City, has utilised their access to the club’s players to deliver engaging content and to highlight their unique offerings. This year, Manchester City stars Erling Haaland, Kyle Walker, and Rodri compete head-to-head for the edge in various challenges such as ball-sorting and tower building.

Hannah Hill, Head of Brand and Sponsorship at Axi, expressed her enthusiasm for their new campaign, stating, “As with every year, working with the City players was, once again, very exciting. They displayed amazing chemistry with each other, and this made for some great banter and amazing content. The collaboration was a unique way to introduce our latest offering, Axi Select. With our new programme, our clients can access the competitive edge they need to become pro traders.”

In September, the broker proudly launched their new capital allocation programme, Axi Select. Aimed to empower ambitious traders and facilitate their progression into professional trading, the programme offers traders the opportunity to access capital funding up to $1,000,000 USD, as well as other exceptional advantages including zero registration fees, and the potential to earn up to 90% of their profits.

Talking about Axi Select when it debuted, Louis Cooper, Chief Commercial Officer at Axi, said, “At Axi, we take pride in being a brand that consistently brings the edge to life for our customers. Our revolutionary new offering, Axi Select, is the first-of-its-kind among brokers and another true reflection of our brand promise. With Axi Select, we deliver unparalleled opportunities to our traders whilst both redefining the boundaries of what’s possible in trading and reshaping the evolution of the financial industry.”

For more information about Axi Select, visit https://www.axi.com/int/funded-trader-programme.
Watch video https://www.youtube.com/watch?v=eDZeNJGi_UU

About Axi

Axi is a global online FX and CFDs trading broker. As the preferred broker for thousands of ambitious customers in over 100 countries worldwide, we help all types of traders, trading businesses, banks and financial organizations find the edge they need to achieve their financial goals through informed transactions made on the world’s financial markets. Axi offers a comprehensive range of assets including CFDs for several asset classes such as Forex, Shares, Oil, Precious Metals, Coffee, Indices, and other commodities.

For other Axi communications, visit https://www.axi.com/int/blog/company-news

For enquiries contact service@axi.com

GlobeNewswire Distribution ID 1000900242

November 20, 2023

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies

DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced a partnership with Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, to use Medidata AI Intelligent Trials to increase access to diverse patients in clinical trials conducted by Fortrea.

Fortrea’s use of Medidata AI builds on an existing collaboration between the two companies, expanding on Fortrea’s use of Medidata Rave EDC, an advanced, robust, and secure EDC system for clinical trial site, patient and lab data capture and management. Fortrea will leverage features of Medidata AI Intelligent Trials, including study feasibility and diversity data, to help emerging and large biopharmas, as well as medical device and diagnostic companies, achieve enrollment goals that reflect the populations most impacted by each disease or condition under study.

“Medidata’s data and interface capabilities will enhance our ability to seamlessly integrate diverse populations into the clinical trial process,” said Fortrea COO and President of Clinical Services Mark Morais. “We are thrilled to work with Medidata as part of Fortrea’s go-forward data strategy.”

“Fortrea and Medidata share a commitment to advancing clinical trial research and this partnership is poised to reshape the landscape of diversity in clinical trials globally,” said Fareed Melhem, SVP, Medidata AI. “Together, our solutions support customers in life sciences to accelerate study timelines and make the benefits of clinical therapies more accessible to a diverse spectrum of individuals.”

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Fortrea Contacts:
Jennifer Minx (Media) – 919-410-4195, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Hima Inguva (Investors) – 877-495-0816, Investors@fortrea.com